from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2667/clpC2

LFCtreatmentdescriptionclass of inhibitor

0.411

Amikacinug/mL Amikacintranslation

-0.142

Cap5-10ug/mL Capreomycintranslation

-0.140

Rox10-50 ug/mL Roxithromycintranslation

-0.315

SM2-5 ug/mL Streptomycintranslation

0.847

Tet5-10 ug/mL Tetracyclinetranslation

1.712

Rif0.2-5ug/mL Rifampicintranscription

1.721

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.889

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.098

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.022

CPZ10-50 ug/mL Chlorpromazinerespiration

0.056

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.296

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.222

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.605

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.539

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.301

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.011

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.115

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.260

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.125

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.153

KCN5-20 ug/mL Potassium cyaniderespiration

-0.293

NaN30.2-2 mM Sodium aziderespiration

-0.662

Nigericin50 uM Nigericinrespiration

0.737

TRC10-150 ug/mL Triclosanrespiration

1.381

TRZ10-25 ug/mL Thioridazinerespiration

1.901

Valinomycin0.5-10 uM Valinomycinrespiration

-1.123

ZnSO42 mM ZnSO4respiration

0.039

menadione6-10 ug/mL Menadionerespiration

0.160

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.532

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.242

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.546

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.028

NRP_1Non-replicating persistence stage 1dosRassociated

-0.527

Amp0.2mg/mL AmpicillincellWall

-0.429

Cephalexin20-100 ug/mL CephalexincellWall

-0.443

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.171

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.305

EMB10-20 ug/mL EthambutolcellWall

-0.817

Eta12-40 ug/mL EthionamidecellWall

-0.771

INH0.2-0.4 ug/mL IsoniazidcellWall

0.395

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.325

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.393

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.553

BZA0.12 mg/mL BenzamidearomaticAmides

0.017

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.677

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.694

H2O24 mM hydrogen peroxideDNAdamaging

0.254

Levo10 ug/mL LevofloxacinDNAdamaging

-0.849

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.789

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.501

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.237

UVUV-irradiationDNAdamaging

1.226

ARP41-4 ug/mL Antitubercular compound ARP4?

0.113

Antimycin12.5-50 ug/mL Antimycin A?

-0.043

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.057

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.096

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.988

PA8240.2-2 ug/mL PA-824?

-0.263

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.396

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.448

Verapamil50 uM Verapamil?

0.405

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.084

methoxatin10-20 ug/mL Methoxatin?